TAKEDA PHARMA A/S: Financial statements 2016
CVR: 16406899
Source: annual report 2016, Danish Business Authority
01/04/2015 – 31/03/2016
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 1,682,747,000 and a net result of DKK 25,296,957,000. The profit margin was 1,503.3%. Equity in the 2016 report amounted to DKK 100,236,684,000. The solvency ratio was 99.3%. The company had 488 employees in the financial year.
- Revenue
- DKK 1,682,747,000
- Gross Profit
- DKK 212,494,000
- Profit/Loss
- DKK 25,296,957,000
- Equity
- DKK 100,236,684,000
- Total Assets
- DKK 100,965,714,000
- Employees
- 488
Official annual report
Find more companies like TAKEDA PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of November 14, 2016, Niels Hansen has joined the board of directors of TAKEDA PHARMA A/S.
As of October 31, 2016, Lisbet Rankløve has left the board of directors of TAKEDA PHARMA A/S.
As of March 9, 2016, Jean Luc Delay has joined the board of directors of TAKEDA PHARMA A/S.
As of March 9, 2016, Dennis-Oliver Lauth has left the board of directors of TAKEDA PHARMA A/S.
About TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.